The role of pharmacogenomics in adverse drug reactions

R Cacabelos, N Cacabelos, JC Carril - Expert Review of Clinical …, 2019 - Taylor & Francis
ABSTRACT Introduction: Adverse drug reactions (ADRs) are a major health concern
worldwide. There are multiple causes of ADRs, some of which are preventable …

Toxicity and pharmacogenomic biomarkers in breast cancer chemotherapy

ZN Al-Mahayri, GP Patrinos, BR Ali - Frontiers in pharmacology, 2020 - frontiersin.org
Breast cancer (BC) is one of the most prevalent types of cancer worldwide with high
morbidity and mortality rates. Treatment modalities include systemic therapy, in which …

[BOEK][B] Human drug metabolism

MD Coleman - 2020 - books.google.com
Provides a timely update to a key textbook on human drug metabolism The third edition of
this comprehensive book covers basic concepts of teaching drug metabolism, starting from …

Genetic and epigenetic regulation of gene expression in fetal and adult human livers

MJ Bonder, S Kasela, M Kals, R Tamm, K Lokk… - BMC genomics, 2014 - Springer
Background The liver plays a central role in the maintenance of homeostasis and health in
general. However, there is substantial inter-individual variation in hepatic gene expression …

Validating the pharmacogenomics of chemotherapy-induced cardiotoxicity: What is missing?

T Magdy, BT Burmeister, PW Burridge - Pharmacology & therapeutics, 2016 - Elsevier
The cardiotoxicity of certain chemotherapeutic agents is now well-established, and has led
to the development of the field of cardio-oncology, increased cardiac screening of cancer …

The mechanisms of multidrug resistance of breast cancer and research progress on related reversal agents

S Yu, J Zheng, Y Zhang, D Meng, Y Wang, X Xu… - Bioorganic & Medicinal …, 2023 - Elsevier
Chemotherapy is the mainstay in the treatment of breast cancer. However, many drugs that
are commonly used in clinical practice have a high incidence of side effects and multidrug …

Pharmacogenetics of toxicity of 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients

K Tecza, J Pamula-Pilat, J Lanuszewska… - …, 2018 - pmc.ncbi.nlm.nih.gov
The differences in patients' response to the same medication, toxicity included, are one of
the major problems in breast cancer treatment. Chemotherapy toxicity makes a significant …

The relation of Haplotype ATP-binding cassette B1 and Glutathione S-transferase P1 A313G genes with hematological toxicity in Indonesian breast cancer patients …

S Syarifah, T Widyawati, D Hasni, MI Sari… - Oman Medical …, 2022 - pmc.ncbi.nlm.nih.gov
Objectives Hematological toxicity induced by chemotherapy is known to be caused by
multiple factors, including genetic factors such as polymorphisms. The polymorphisms may …

Polymorphisms in GSTT1 and GSTM1 genes as possible risk factors for susceptibility to breast cancer development and their influence in chemotherapy response: a …

LM Pacholak, MK Amarante, RL Guembarovski… - Molecular Biology …, 2020 - Springer
Breast cancer (BC) is a heterogeneous and multifactorial disease. The system formed by
glutathione-S-transferases (GSTs) acts to protect the organism against the oxidative stress …

Oxidative stress-related genetic polymorphisms are associated with the prognosis of metastatic gastric cancer patients treated with epirubicin, oxaliplatin and 5 …

R Geng, Z Chen, X Zhao, L Qiu, X Liu, R Liu, W Guo… - PloS one, 2014 - journals.plos.org
Background Oxidative stress genes are related to cancer development and treatment
response. In this study, we aimed to determine the predictive and prognostic roles of …